Autophagy is an important cellular degradation pathway with a central role in 24 metabolism as well as basic quality control, two processes inextricably linked to aging.
that became progressively more pronounced as the animals aged until death, whilst 145 16/28 LT-Atg5i mice displayed evidence of premature greying to varying degrees ( Fig.   146 1h). Furthermore LT-Atg5i mice displayed evidence of extramedullary hematopoiesis 147 ( Fig. 2a ) and immune aggregations, commonly seen in aged mouse colonies, were 148 also found in the liver, lungs and kidneys but were generally absent in age matched 149 controls, although incidence of these increased in frequency with increasing age 150 ( Supplementary Fig. 3a ).
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As previously described in hematopoietic Atg5 KO mice, LT-Atg5i mice also displayed 153 an increase in cellularity of the peripheral immune system 18,20 ( Supplementary Fig. 3b) 154 with a myeloid skewing ( Fig. 2b ) reminiscent of age-associated chronic inflammation.
155
This 'inflamm-aging' phenotype was further supported by an increase in serum TNF 156 and IL-6 in LT-Atg5i mice in comparison to control (Fig. 2c ).
The accumulation of senescent cells is considered a key marker of chronological 171 aging. Autophagy has been reported to have context dependent and sometimes 172 opposing roles during cellular senescence: typically basal autophagy is considered to 173 promote fitness and its loss may promote senescence, whereas in oncogene-induced 174 senescence, autophagy may be important for the establishment of senescent 175 phenotypes [23] [24] [25] [26] . To determine if the systemic loss of basal autophagy is sufficient to 176 drive the establishment of cellular senescence in vivo we performed western blotting 177 across a number of tissues from 4-month dox treated LT-Atg5i mice and found an 178 increased staining pattern for key senescence markers (i.e. p16, p21, and p53) ( Fig.   179 3a-c and Supplementary Fig. 3c ). Additionally, whole mount senescence-associated 180 beta-galactosidase staining from 6-month treated livers highlighted a marked increase 181 in staining patterns in comparison to LT-Control mice (Fig. 3d ). Histologically, nuclear 182 accumulation of p21 was also evident, particularly in hepatocytes with enlarged 183 morphology ( Fig. 3d ). Furthermore LT-Atg5i mice display a significant increase in both 184 the abundance and frequency of telomere-associated γ-H2AX foci (TAF), which have 185 been shown to correlate with senescence, increasing age and mitochondrial 186 dysfunction ( Fig. 3e, f) [27] [28] [29] . These data reinforce the age acceleration upon systemic 187 autophagy reduction.
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Of note, similar gross phenotypic results were also seen in mice with a second hairpin 190 targeting Atg5 (LT-Atg5i_2). LT-Atg5i_2 mice display evidence of premature aging-like 191 phenotypes ( Supplementary Fig. 4a-c) , however the appearance of these phenotypes 192 is delayed in comparison to LT-Atg5i mice, seemingly due to a hypomorphic reduction 193 in Atg5. Accordingly, these mice displayed the accumulation of p62/Sqstm1 and LC3 194 in multiple tissues but at lower levels in comparison to LT-Atg5i mice, and did not 
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Combined these data support a role for basal autophagy in maintaining tissue and 203 organismal homeostasis and provide evidence that causally links autophagy inhibition 204 to the induction of aging-like phenotypes in mammals.
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Autophagy Restoration Partially Reverses Accelerated Aging-like Phenotypes
207
We next sought to determine whether autophagy restoration alone is able to reverse 208 the aging-like phenotypes by removing dox from the diet. Eight-week old Atg5i and 209 control mice treated with dox for four months, the point at which they universally 210 presented with kyphosis, were switched back to a diet absent of dox leading to a 211 restoration in Atg5 levels and autophagy (termed R-Atg5i cohort) 13 . Interestingly the 212 senescence marker p21 remained elevated across a number of tissues 2 months post 213 dox removal ( Fig. 4a, b ).
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An increase in chronological age is generally associated with the deviations in multiple 216 health parameters that when measured can be combined into a clinical 'frailty-score' 217 30 . As expected R-Atg5i mice displayed an initial increase in their frailty scores during 218 autophagy inhibition in comparison to littermate controls, yet once mice have been 219 switched back to a diet absent of dox, the frailty scores displayed a significant decrease 220 over the next four months ( Fig. 4c , Supplementary Movie. 1). In contrast, LT-Atg5i mice 221 treated on dox for 6 months (median survival is around ~6 months on dox) continued 222 to display a significant difference in their frailty scores, while almost all LT-Atg5i mice 223 had already succumbed by eight-months ( Fig. 4c ). A similar increase in frailty was also 224 noted in the LT-Atg5i_2 cohorts ( Supplementary Fig. 4b ). The penetrant kyphosis 225 phenotype was largely irreversible, however 3/26 R-Atg5i mice did show evidence of 226 recovery from kyphosis, while no mice displayed a reversal of the greying phenotypes.
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As such, while autophagy inhibition in vivo appears to promote frailty, autophagy 228 restoration is seemingly able to substantially reverse this effect.
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Remarkably the profound immune-associated phenotypes that we observed in Supplementary Fig. 5a ). However, it should be noted that there 234 was a trend towards a larger red blood cell distribution width (RDW) in aged R-Atg5i 235 mice removed from dox for 8 months (14 months old), which has previously been linked 236 to a range of diseases and an increased risk of acute myeloid leukemia (AML) ( Supplementary Fig. 5g ).
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Similarly, the protein aggregation marker p62/SQSTM1 in the liver appeared much 246 reduced in R-Atg5i mice in comparison to the LT-Atg5i mice, yet a small but substantial 247 number of cells still exhibited a marked accumulation of p62 aggregation in R-Atg5i 248 mice that had been off dox for four months (Fig. 5a ). Additionally, R-Atg5i livers were 249 also found to contain the presence of ceroid-laden macrophages and lipofuscin 250 positivity, pigments known to increase with age and not seen in age-matched controls 251 mice ( Fig. 5b) . Importantly, and in accordance with this partial restoration phenotype, 252 molecular markers of aging such as TAF also remained significantly elevated in R-
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Atg5i mice. This is consistent with the persistent nature of telomeric DNA damage,
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which is reported to be irreparable 27, 32 . Together with other senescence markers ( Fig.   255 4b), these data suggest that a portion of the cellular damage caused by a chronic block 256 in autophagy is irreversible ( Fig. 5c ).
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Morphological analysis of skeletal muscle from R-Atg5i mice with autophagy restored 259 suggests that muscle fibre size and morphology display no sign of recovery at the 260 timepoint analysed (Fig. 5d , e and Supplementary Fig. 6a, b ). However central 261 nucleation and satellite cell frequency appeared to display a heterogeneous pattern,
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with evidence of recovery apparent in some individuals ( Fig. 5f , g). As expected with 263 Atg5 restoration, mitochondrial levels as determined by Tom20 positivity were restored 264 to control levels ( Fig. 5h ). Additionally, the cardiac fibrosis observed LT-Atg5i mice 265 appears to still be present four months post dox removal in R-Atg5i cohorts 266 ( Supplementary Fig. 6c ). Together these data suggest that autophagy restoration may 267 have tissue and pathology specific limitations in the capacity to recover from the tissue 268 and cellular damage induced upon its inhibition. Crucially, whilst some tissues, such 269 as the liver, appear to recover, they are still associated with age-associated 270 pathologies at the molecular level. 
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Our findings support the theory that a reduction in autophagy is sufficient to induce 299 several molecular and phenotypic characteristics associated with mammalian aging, 300 including the development of age-associated diseases and a reduction in longevity.
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Here it is notable that our Atg5i mice phenocopy other models of aging driven by the 
